Ellen Gravallese
Concepts (451)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Arthritis, Rheumatoid | 41 | 2020 | 232 | 9.400 |
Why?
| Bone Resorption | 15 | 2015 | 44 | 4.610 |
Why?
| Arthritis, Experimental | 10 | 2016 | 36 | 2.750 |
Why?
| Osteoclasts | 18 | 2015 | 62 | 2.580 |
Why?
| Osteoblasts | 9 | 2016 | 156 | 2.460 |
Why?
| Synovial Membrane | 11 | 2006 | 28 | 1.720 |
Why?
| Cytokines | 10 | 2015 | 719 | 1.430 |
Why?
| Bone and Bones | 12 | 2014 | 110 | 1.410 |
Why?
| Bone Remodeling | 4 | 2014 | 26 | 1.380 |
Why?
| RNA, Messenger | 15 | 2016 | 1254 | 1.360 |
Why?
| Membrane Glycoproteins | 9 | 2015 | 623 | 1.280 |
Why?
| Tumor Necrosis Factor-alpha | 11 | 2017 | 489 | 1.150 |
Why?
| Joints | 6 | 2012 | 26 | 1.030 |
Why?
| RANK Ligand | 8 | 2014 | 30 | 0.980 |
Why?
| RNA | 4 | 2020 | 284 | 0.970 |
Why?
| Bone Density | 4 | 2017 | 135 | 0.970 |
Why?
| Inflammation | 9 | 2014 | 666 | 0.940 |
Why?
| Arthritis | 7 | 2015 | 41 | 0.860 |
Why?
| Spondylarthropathies | 2 | 2010 | 5 | 0.800 |
Why?
| DNA-Binding Proteins | 11 | 2014 | 1007 | 0.800 |
Why?
| Carrier Proteins | 7 | 2014 | 615 | 0.790 |
Why?
| Teriparatide | 1 | 2017 | 4 | 0.770 |
Why?
| Glycoproteins | 8 | 2009 | 158 | 0.770 |
Why?
| Bone Diseases, Metabolic | 1 | 2017 | 23 | 0.760 |
Why?
| Bone Density Conservation Agents | 1 | 2017 | 46 | 0.750 |
Why?
| Animals | 38 | 2016 | 14702 | 0.740 |
Why?
| Autoantibodies | 3 | 2015 | 117 | 0.730 |
Why?
| Osteogenesis | 4 | 2012 | 87 | 0.730 |
Why?
| Humans | 56 | 2020 | 34159 | 0.730 |
Why?
| Endodeoxyribonucleases | 3 | 2016 | 35 | 0.720 |
Why?
| Wnt Proteins | 3 | 2012 | 93 | 0.720 |
Why?
| Bone Morphogenetic Protein 3 | 1 | 2016 | 2 | 0.710 |
Why?
| Toll-Like Receptors | 2 | 2015 | 423 | 0.670 |
Why?
| Antibody Formation | 2 | 2014 | 103 | 0.640 |
Why?
| Spondylitis, Ankylosing | 2 | 2014 | 16 | 0.630 |
Why?
| Mice | 28 | 2016 | 7378 | 0.630 |
Why?
| Receptors, Tumor Necrosis Factor | 7 | 2006 | 64 | 0.580 |
Why?
| Bone Diseases | 2 | 2009 | 23 | 0.570 |
Why?
| Rheumatology | 2 | 2003 | 30 | 0.560 |
Why?
| Inflammation Mediators | 4 | 2015 | 134 | 0.560 |
Why?
| Alternative Splicing | 1 | 2013 | 101 | 0.540 |
Why?
| Cell Differentiation | 11 | 2014 | 1044 | 0.540 |
Why?
| Receptors, Cytoplasmic and Nuclear | 5 | 2006 | 127 | 0.520 |
Why?
| Mice, Inbred C57BL | 11 | 2016 | 2282 | 0.520 |
Why?
| Methotrexate | 1 | 2011 | 70 | 0.500 |
Why?
| Antirheumatic Agents | 5 | 2017 | 113 | 0.480 |
Why?
| Metalloendopeptidases | 3 | 1996 | 29 | 0.460 |
Why?
| Collagenases | 3 | 2005 | 17 | 0.420 |
Why?
| Osteoporosis, Postmenopausal | 1 | 2009 | 64 | 0.420 |
Why?
| T-Lymphocytes | 2 | 2013 | 898 | 0.420 |
Why?
| Receptor Activator of Nuclear Factor-kappa B | 7 | 2014 | 15 | 0.420 |
Why?
| Macrophages | 6 | 2014 | 729 | 0.390 |
Why?
| Disease Models, Animal | 8 | 2016 | 1190 | 0.380 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2016 | 530 | 0.380 |
Why?
| Male | 22 | 2017 | 17242 | 0.380 |
Why?
| Sialoglycoproteins | 2 | 2004 | 20 | 0.370 |
Why?
| Amyloidosis | 2 | 2000 | 27 | 0.360 |
Why?
| Signal Transduction | 9 | 2015 | 2302 | 0.360 |
Why?
| Immunohistochemistry | 9 | 2009 | 774 | 0.360 |
Why?
| Myocarditis | 2 | 1998 | 15 | 0.360 |
Why?
| Female | 27 | 2017 | 18881 | 0.350 |
Why?
| Middle Aged | 20 | 2017 | 9874 | 0.350 |
Why?
| Transcription Factors | 9 | 2005 | 1199 | 0.350 |
Why?
| Synovitis, Pigmented Villonodular | 2 | 1997 | 5 | 0.350 |
Why?
| Lyme Disease | 2 | 1998 | 59 | 0.340 |
Why?
| Treatment Outcome | 7 | 2017 | 2667 | 0.340 |
Why?
| Osteoprotegerin | 5 | 2006 | 11 | 0.330 |
Why?
| Lupus Erythematosus, Systemic | 1 | 2005 | 71 | 0.330 |
Why?
| Severity of Illness Index | 5 | 2017 | 893 | 0.330 |
Why?
| Knee Joint | 3 | 2013 | 66 | 0.320 |
Why?
| Blotting, Western | 4 | 2016 | 538 | 0.320 |
Why?
| Autoimmunity | 2 | 2016 | 145 | 0.320 |
Why?
| Aged | 15 | 2017 | 7641 | 0.310 |
Why?
| Diphosphonates | 1 | 2004 | 32 | 0.310 |
Why?
| Radiography | 5 | 2013 | 311 | 0.310 |
Why?
| Mice, Knockout | 8 | 2016 | 1606 | 0.310 |
Why?
| In Situ Hybridization | 6 | 2009 | 201 | 0.290 |
Why?
| Angiogenesis Inducing Agents | 1 | 2003 | 9 | 0.280 |
Why?
| Conflict of Interest | 1 | 2003 | 25 | 0.280 |
Why?
| Peer Review, Research | 1 | 2003 | 33 | 0.280 |
Why?
| Disclosure | 1 | 2003 | 37 | 0.280 |
Why?
| Truth Disclosure | 1 | 2003 | 45 | 0.280 |
Why?
| Lipopolysaccharides | 4 | 2005 | 516 | 0.280 |
Why?
| Editorial Policies | 1 | 2003 | 28 | 0.270 |
Why?
| Crohn Disease | 2 | 1995 | 48 | 0.260 |
Why?
| Societies, Medical | 1 | 2003 | 159 | 0.260 |
Why?
| Histocompatibility Antigens Class II | 3 | 1995 | 153 | 0.260 |
Why?
| NF-kappa B | 4 | 2014 | 386 | 0.260 |
Why?
| Interleukin-1 | 5 | 2003 | 148 | 0.260 |
Why?
| Acid Phosphatase | 4 | 2012 | 11 | 0.260 |
Why?
| Polymyositis | 1 | 2000 | 2 | 0.230 |
Why?
| Tomography, X-Ray Computed | 4 | 2017 | 853 | 0.230 |
Why?
| Intercellular Signaling Peptides and Proteins | 2 | 2012 | 102 | 0.230 |
Why?
| Antigens, CD | 4 | 2006 | 292 | 0.230 |
Why?
| Interleukin-4 | 3 | 1998 | 204 | 0.220 |
Why?
| Up-Regulation | 4 | 2013 | 322 | 0.210 |
Why?
| Osteoporosis | 1 | 1999 | 113 | 0.210 |
Why?
| Cartilage, Articular | 2 | 2013 | 22 | 0.210 |
Why?
| Toll-Like Receptor 7 | 2 | 2015 | 67 | 0.200 |
Why?
| Isoenzymes | 3 | 2012 | 131 | 0.200 |
Why?
| Proto-Oncogene Proteins | 3 | 2005 | 274 | 0.200 |
Why?
| Metacarpophalangeal Joint | 1 | 2017 | 4 | 0.190 |
Why?
| Ulna | 1 | 2017 | 5 | 0.190 |
Why?
| Radius | 1 | 2017 | 7 | 0.190 |
Why?
| Hand | 3 | 2009 | 41 | 0.190 |
Why?
| Giant Cell Tumors | 1 | 1997 | 7 | 0.190 |
Why?
| Synovitis | 2 | 1995 | 16 | 0.190 |
Why?
| Th1 Cells | 1 | 1998 | 128 | 0.190 |
Why?
| Tendons | 1 | 1997 | 16 | 0.190 |
Why?
| Cohort Studies | 2 | 2013 | 1417 | 0.190 |
Why?
| Osteoarthritis | 4 | 2003 | 33 | 0.180 |
Why?
| Fenretinide | 1 | 1996 | 2 | 0.180 |
Why?
| Interleukin-1beta | 2 | 2015 | 183 | 0.180 |
Why?
| Phenotype | 3 | 2015 | 803 | 0.180 |
Why?
| Hand Bones | 1 | 2016 | 2 | 0.180 |
Why?
| Hand Joints | 1 | 2016 | 2 | 0.180 |
Why?
| Skull | 1 | 2016 | 35 | 0.170 |
Why?
| B-Lymphocytes | 4 | 2001 | 540 | 0.170 |
Why?
| Transcription, Genetic | 4 | 2004 | 786 | 0.170 |
Why?
| Toll-Like Receptor 3 | 1 | 2015 | 59 | 0.170 |
Why?
| Genes, MHC Class II | 2 | 1995 | 34 | 0.170 |
Why?
| Stromal Cells | 1 | 2016 | 51 | 0.170 |
Why?
| Mycobacterium Infections | 1 | 1995 | 11 | 0.170 |
Why?
| Polyarteritis Nodosa | 1 | 1995 | 5 | 0.170 |
Why?
| Arthritis, Infectious | 1 | 1995 | 18 | 0.170 |
Why?
| Hip Prosthesis | 1 | 1995 | 20 | 0.170 |
Why?
| Interferon Regulatory Factors | 1 | 2015 | 35 | 0.170 |
Why?
| DNA Primers | 3 | 2009 | 301 | 0.170 |
Why?
| Myxoma | 1 | 1995 | 13 | 0.170 |
Why?
| Adaptor Proteins, Vesicular Transport | 1 | 2015 | 74 | 0.170 |
Why?
| Prosthesis Failure | 1 | 1995 | 42 | 0.170 |
Why?
| Myeloid Cells | 1 | 2015 | 55 | 0.170 |
Why?
| Prosthesis-Related Infections | 1 | 1995 | 24 | 0.170 |
Why?
| DNA | 3 | 2015 | 608 | 0.170 |
Why?
| Proteins | 1 | 2000 | 578 | 0.160 |
Why?
| Heart Neoplasms | 1 | 1995 | 26 | 0.160 |
Why?
| Cells, Cultured | 4 | 2014 | 1798 | 0.160 |
Why?
| Toll-Like Receptor 5 | 1 | 2014 | 9 | 0.160 |
Why?
| Myeloid Progenitor Cells | 1 | 2014 | 13 | 0.160 |
Why?
| Endosomes | 1 | 2015 | 136 | 0.160 |
Why?
| Immunoblastic Lymphadenopathy | 1 | 1994 | 2 | 0.160 |
Why?
| Hematopoietic Stem Cells | 1 | 2016 | 211 | 0.150 |
Why?
| Peritonitis | 1 | 2014 | 22 | 0.150 |
Why?
| Peritoneum | 1 | 2014 | 28 | 0.150 |
Why?
| Base Sequence | 4 | 2009 | 1244 | 0.150 |
Why?
| Antigens, Neoplasm | 1 | 1995 | 98 | 0.150 |
Why?
| Cluster Analysis | 1 | 2014 | 203 | 0.150 |
Why?
| Blood Sedimentation | 1 | 2014 | 9 | 0.150 |
Why?
| Collagen Type II | 1 | 2014 | 10 | 0.150 |
Why?
| Nephrogenic Fibrosing Dermopathy | 1 | 2014 | 21 | 0.150 |
Why?
| Autoantigens | 1 | 2014 | 96 | 0.150 |
Why?
| Gadolinium | 1 | 2014 | 53 | 0.150 |
Why?
| Posterior Cruciate Ligament | 1 | 2013 | 1 | 0.150 |
Why?
| Anterior Cruciate Ligament | 1 | 2013 | 10 | 0.150 |
Why?
| Angiopoietin-1 | 2 | 2004 | 3 | 0.150 |
Why?
| Cathepsins | 3 | 2006 | 30 | 0.140 |
Why?
| Polymerase Chain Reaction | 2 | 2009 | 452 | 0.140 |
Why?
| Blood Vessels | 1 | 2013 | 44 | 0.140 |
Why?
| Jurkat Cells | 1 | 2013 | 69 | 0.140 |
Why?
| Spine | 2 | 2009 | 39 | 0.140 |
Why?
| Antineoplastic Agents | 1 | 1996 | 339 | 0.140 |
Why?
| C-Reactive Protein | 1 | 2014 | 164 | 0.140 |
Why?
| Lymphocyte Activation | 3 | 2013 | 686 | 0.140 |
Why?
| Osteoarthritis, Knee | 1 | 2013 | 49 | 0.140 |
Why?
| Adult | 10 | 2016 | 9698 | 0.140 |
Why?
| Protein Isoforms | 1 | 2013 | 168 | 0.140 |
Why?
| Mice, Transgenic | 3 | 2012 | 945 | 0.140 |
Why?
| Contrast Media | 1 | 2014 | 233 | 0.140 |
Why?
| Hip Joint | 2 | 2009 | 24 | 0.140 |
Why?
| Terminology as Topic | 1 | 2013 | 103 | 0.140 |
Why?
| Bone Regeneration | 1 | 2012 | 9 | 0.130 |
Why?
| Gene Expression Profiling | 1 | 2014 | 479 | 0.130 |
Why?
| Follistatin-Related Proteins | 1 | 2012 | 17 | 0.130 |
Why?
| beta 2-Microglobulin | 1 | 1992 | 53 | 0.130 |
Why?
| Muscular Diseases | 1 | 1992 | 36 | 0.130 |
Why?
| Cell Line, Tumor | 2 | 2013 | 857 | 0.130 |
Why?
| Microbial Collagenase | 1 | 1991 | 3 | 0.130 |
Why?
| Diagnosis, Differential | 4 | 2001 | 637 | 0.130 |
Why?
| Collagen | 3 | 2014 | 119 | 0.130 |
Why?
| Nucleic Acid Hybridization | 1 | 1991 | 94 | 0.130 |
Why?
| Blotting, Northern | 3 | 2003 | 158 | 0.130 |
Why?
| Gene Expression | 4 | 2000 | 610 | 0.120 |
Why?
| Nuclear Proteins | 4 | 2005 | 695 | 0.120 |
Why?
| Cartilage | 4 | 2005 | 26 | 0.120 |
Why?
| Drug Therapy, Combination | 1 | 2011 | 344 | 0.120 |
Why?
| Matrix Metalloproteinase 3 | 3 | 1996 | 8 | 0.120 |
Why?
| Immunity, Innate | 1 | 2014 | 539 | 0.120 |
Why?
| Metacarpal Bones | 1 | 2009 | 1 | 0.120 |
Why?
| Calcification, Physiologic | 1 | 2009 | 12 | 0.110 |
Why?
| Spondylarthritis | 1 | 2009 | 4 | 0.110 |
Why?
| Aortitis | 1 | 1989 | 6 | 0.110 |
Why?
| Rheumatic Diseases | 1 | 2009 | 21 | 0.110 |
Why?
| Monocytes | 2 | 2014 | 299 | 0.100 |
Why?
| Colitis, Ulcerative | 1 | 1988 | 27 | 0.100 |
Why?
| Antibodies | 2 | 2014 | 151 | 0.100 |
Why?
| Linear Models | 1 | 2009 | 335 | 0.100 |
Why?
| Chondrocytes | 2 | 2005 | 41 | 0.100 |
Why?
| Fractures, Bone | 1 | 2009 | 115 | 0.100 |
Why?
| Health Surveys | 1 | 2009 | 262 | 0.100 |
Why?
| Cathepsin K | 3 | 2006 | 8 | 0.100 |
Why?
| Fibroblasts | 3 | 2004 | 287 | 0.100 |
Why?
| Disease Progression | 3 | 2004 | 479 | 0.100 |
Why?
| Mice, Inbred DBA | 3 | 2014 | 83 | 0.090 |
Why?
| Longitudinal Studies | 1 | 2009 | 693 | 0.090 |
Why?
| Multivariate Analysis | 1 | 2009 | 724 | 0.090 |
Why?
| Osteopontin | 2 | 2004 | 18 | 0.090 |
Why?
| Biopsy | 2 | 2000 | 263 | 0.090 |
Why?
| Mice, Inbred C3H | 2 | 1998 | 173 | 0.090 |
Why?
| Prosthesis Implantation | 1 | 2006 | 19 | 0.090 |
Why?
| Osteolysis | 1 | 2006 | 20 | 0.090 |
Why?
| Immunoenzyme Techniques | 2 | 2003 | 110 | 0.090 |
Why?
| Clinical Trials as Topic | 2 | 2011 | 309 | 0.090 |
Why?
| Parathyroid Hormone-Related Protein | 1 | 2005 | 7 | 0.090 |
Why?
| Arthroplasty, Replacement | 1 | 2006 | 17 | 0.090 |
Why?
| Prostaglandins | 1 | 2005 | 32 | 0.090 |
Why?
| Antigens, CD14 | 2 | 1997 | 150 | 0.080 |
Why?
| Synovial Fluid | 2 | 2015 | 26 | 0.080 |
Why?
| Enzyme Induction | 1 | 2005 | 37 | 0.080 |
Why?
| Prostaglandin-Endoperoxide Synthases | 1 | 2005 | 27 | 0.080 |
Why?
| Membrane Transport Proteins | 2 | 2016 | 103 | 0.080 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2005 | 118 | 0.080 |
Why?
| Imidazoles | 1 | 2004 | 56 | 0.080 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2005 | 222 | 0.070 |
Why?
| Antigens, Differentiation, Myelomonocytic | 2 | 2006 | 19 | 0.070 |
Why?
| Autoimmune Diseases | 1 | 2004 | 156 | 0.070 |
Why?
| Child, Preschool | 2 | 2006 | 1311 | 0.070 |
Why?
| Angiopoietin-2 | 1 | 2003 | 2 | 0.070 |
Why?
| Culture Techniques | 1 | 2003 | 14 | 0.070 |
Why?
| Immunoglobulin G | 2 | 2002 | 337 | 0.070 |
Why?
| Receptors, Calcitonin | 2 | 2006 | 2 | 0.070 |
Why?
| Cell Movement | 2 | 2014 | 336 | 0.070 |
Why?
| Image Processing, Computer-Assisted | 2 | 2016 | 426 | 0.070 |
Why?
| Still's Disease, Adult-Onset | 1 | 2002 | 2 | 0.070 |
Why?
| Epitopes | 1 | 2003 | 240 | 0.070 |
Why?
| Fingers | 2 | 1995 | 34 | 0.070 |
Why?
| Aged, 80 and over | 5 | 1997 | 2864 | 0.070 |
Why?
| DNA, Complementary | 2 | 2004 | 180 | 0.070 |
Why?
| Dermatomyositis | 1 | 2001 | 2 | 0.070 |
Why?
| Cystadenocarcinoma, Papillary | 1 | 2001 | 2 | 0.070 |
Why?
| Paraneoplastic Syndromes | 1 | 2001 | 6 | 0.070 |
Why?
| Aorta, Thoracic | 2 | 1994 | 53 | 0.060 |
Why?
| Risk Factors | 1 | 2009 | 3030 | 0.060 |
Why?
| Proto-Oncogene Proteins c-jun | 2 | 2005 | 24 | 0.060 |
Why?
| Ovarian Neoplasms | 1 | 2001 | 79 | 0.060 |
Why?
| Plasma Cells | 1 | 2001 | 39 | 0.060 |
Why?
| Trans-Activators | 1 | 2003 | 278 | 0.060 |
Why?
| Blood Transfusion | 1 | 2001 | 124 | 0.060 |
Why?
| TNF Receptor-Associated Factor 5 | 1 | 2000 | 1 | 0.060 |
Why?
| TNF Receptor-Associated Factor 4 | 1 | 2000 | 1 | 0.060 |
Why?
| CD4-Positive T-Lymphocytes | 2 | 1995 | 523 | 0.060 |
Why?
| TNF Receptor-Associated Factor 3 | 1 | 2000 | 4 | 0.060 |
Why?
| TNF Receptor-Associated Factor 1 | 1 | 2000 | 3 | 0.060 |
Why?
| TNF Receptor-Associated Factor 2 | 1 | 2000 | 13 | 0.060 |
Why?
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2000 | 7 | 0.060 |
Why?
| TNF Receptor-Associated Factor 6 | 1 | 2000 | 21 | 0.060 |
Why?
| NFATC Transcription Factors | 4 | 2005 | 19 | 0.060 |
Why?
| Child | 2 | 2006 | 2648 | 0.060 |
Why?
| Gout | 2 | 1993 | 39 | 0.060 |
Why?
| Receptors, Interleukin-1 | 2 | 2015 | 63 | 0.060 |
Why?
| Macrophage Colony-Stimulating Factor | 1 | 2000 | 30 | 0.060 |
Why?
| Myofibrils | 1 | 2000 | 11 | 0.060 |
Why?
| Giant Cell Tumor of Bone | 1 | 2000 | 4 | 0.060 |
Why?
| Interleukins | 1 | 2000 | 64 | 0.060 |
Why?
| Proto-Oncogene Proteins c-ets | 3 | 2005 | 18 | 0.060 |
Why?
| Molecular Sequence Data | 3 | 2005 | 2049 | 0.060 |
Why?
| Chondrogenesis | 1 | 2000 | 9 | 0.060 |
Why?
| Oligonucleotide Array Sequence Analysis | 3 | 2005 | 270 | 0.050 |
Why?
| Bone Neoplasms | 1 | 2000 | 94 | 0.050 |
Why?
| Pilot Projects | 2 | 2002 | 497 | 0.050 |
Why?
| Bone Marrow Cells | 1 | 2000 | 214 | 0.050 |
Why?
| Multiple Myeloma | 1 | 2000 | 82 | 0.050 |
Why?
| Immunoglobulin M | 2 | 1998 | 102 | 0.050 |
Why?
| Adolescent | 2 | 2006 | 4025 | 0.050 |
Why?
| Phosphorylation | 2 | 2014 | 672 | 0.050 |
Why?
| Receptors, Parathyroid Hormone | 1 | 1998 | 2 | 0.050 |
Why?
| Heart Valves | 1 | 1998 | 16 | 0.050 |
Why?
| Lymphoid Tissue | 1 | 1998 | 55 | 0.050 |
Why?
| Promoter Regions, Genetic | 3 | 2005 | 579 | 0.050 |
Why?
| Vitronectin | 1 | 1997 | 7 | 0.050 |
Why?
| Gene Expression Regulation | 1 | 2004 | 1217 | 0.050 |
Why?
| HLA-DR Antigens | 1 | 1997 | 27 | 0.050 |
Why?
| Liver | 2 | 1998 | 542 | 0.050 |
Why?
| Liver Cirrhosis | 1 | 1997 | 81 | 0.040 |
Why?
| Membrane Proteins | 2 | 2016 | 650 | 0.040 |
Why?
| Radiation Chimera | 1 | 2016 | 55 | 0.040 |
Why?
| NF-kappa B p50 Subunit | 1 | 1995 | 24 | 0.040 |
Why?
| Hematopoiesis, Extramedullary | 1 | 2015 | 6 | 0.040 |
Why?
| Splenomegaly | 1 | 2015 | 14 | 0.040 |
Why?
| Interferon-gamma | 1 | 1998 | 497 | 0.040 |
Why?
| Drug Administration Schedule | 1 | 1996 | 226 | 0.040 |
Why?
| Receptor, Interferon alpha-beta | 1 | 2015 | 33 | 0.040 |
Why?
| Transcription Factor RelA | 1 | 1995 | 34 | 0.040 |
Why?
| Proto-Oncogene Proteins c-fos | 1 | 1995 | 53 | 0.040 |
Why?
| Muscle, Skeletal | 1 | 2000 | 474 | 0.040 |
Why?
| Cell Line | 3 | 2005 | 1755 | 0.040 |
Why?
| Knee Prosthesis | 1 | 1995 | 6 | 0.040 |
Why?
| Gene Knockdown Techniques | 1 | 2015 | 138 | 0.040 |
Why?
| Antigens, CD20 | 1 | 1995 | 8 | 0.040 |
Why?
| Antigens, CD19 | 1 | 1995 | 17 | 0.040 |
Why?
| Fever | 1 | 1995 | 64 | 0.040 |
Why?
| Chemotactic Factors | 1 | 1995 | 21 | 0.040 |
Why?
| Paraffin Embedding | 1 | 1995 | 14 | 0.040 |
Why?
| Antigens, Differentiation, B-Lymphocyte | 1 | 1995 | 24 | 0.040 |
Why?
| Arthralgia | 1 | 1995 | 34 | 0.040 |
Why?
| Borrelia burgdorferi Group | 1 | 1995 | 25 | 0.040 |
Why?
| Lymphopenia | 1 | 1995 | 40 | 0.040 |
Why?
| Antigens, CD3 | 1 | 1995 | 60 | 0.040 |
Why?
| Chemokine CCL2 | 1 | 1995 | 54 | 0.040 |
Why?
| Flagellin | 1 | 2014 | 8 | 0.040 |
Why?
| Toll-Like Receptor 2 | 1 | 2015 | 234 | 0.040 |
Why?
| B-Lymphocyte Subsets | 1 | 1995 | 55 | 0.040 |
Why?
| Toll-Like Receptor 9 | 1 | 2015 | 155 | 0.040 |
Why?
| Luciferases | 2 | 2005 | 101 | 0.040 |
Why?
| Ligands | 1 | 2015 | 337 | 0.040 |
Why?
| Antigens, CD4 | 1 | 1995 | 123 | 0.040 |
Why?
| Antibodies, Bacterial | 1 | 1995 | 129 | 0.040 |
Why?
| Toll-Like Receptor 4 | 1 | 2015 | 300 | 0.040 |
Why?
| Gadolinium DTPA | 1 | 2014 | 52 | 0.040 |
Why?
| X-Ray Microtomography | 1 | 2014 | 11 | 0.040 |
Why?
| Genes, Reporter | 2 | 2005 | 187 | 0.040 |
Why?
| Genotype | 1 | 2015 | 480 | 0.040 |
Why?
| Ischemia | 1 | 1995 | 128 | 0.040 |
Why?
| Histocytochemistry | 1 | 2014 | 46 | 0.040 |
Why?
| Hearing Disorders | 1 | 1973 | 2 | 0.040 |
Why?
| Streptomycin | 1 | 1973 | 11 | 0.040 |
Why?
| United States | 1 | 2003 | 4021 | 0.040 |
Why?
| Acute-Phase Proteins | 1 | 2014 | 31 | 0.040 |
Why?
| Organometallic Compounds | 1 | 2014 | 66 | 0.040 |
Why?
| JNK Mitogen-Activated Protein Kinases | 1 | 2014 | 115 | 0.040 |
Why?
| Flow Cytometry | 1 | 2016 | 615 | 0.040 |
Why?
| Hindlimb | 1 | 2014 | 42 | 0.040 |
Why?
| Vertigo | 1 | 1973 | 14 | 0.040 |
Why?
| Apoptosis Regulatory Proteins | 1 | 2014 | 114 | 0.040 |
Why?
| Lymph Nodes | 1 | 1994 | 185 | 0.040 |
Why?
| Random Allocation | 1 | 2014 | 166 | 0.040 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 151 | 0.040 |
Why?
| Vision Disorders | 1 | 1973 | 23 | 0.040 |
Why?
| Endocrine Glands | 1 | 1993 | 12 | 0.040 |
Why?
| Myocardium | 1 | 1995 | 196 | 0.040 |
Why?
| Embryonic and Fetal Development | 1 | 1993 | 47 | 0.040 |
Why?
| Arthroscopy | 1 | 1993 | 22 | 0.040 |
Why?
| Bone Development | 2 | 2005 | 32 | 0.030 |
Why?
| Reproducibility of Results | 1 | 2016 | 977 | 0.030 |
Why?
| Shoulder | 1 | 1992 | 14 | 0.030 |
Why?
| Hip | 1 | 1992 | 9 | 0.030 |
Why?
| Wrist | 1 | 1992 | 17 | 0.030 |
Why?
| Cycloheximide | 1 | 1991 | 26 | 0.030 |
Why?
| Antigens, CD8 | 1 | 1991 | 54 | 0.030 |
Why?
| Arthrography | 1 | 2011 | 3 | 0.030 |
Why?
| Metalloproteins | 1 | 1991 | 13 | 0.030 |
Why?
| Binding, Competitive | 1 | 1991 | 95 | 0.030 |
Why?
| Registries | 1 | 2014 | 461 | 0.030 |
Why?
| Time Factors | 2 | 2009 | 2605 | 0.030 |
Why?
| Remission Induction | 1 | 2011 | 92 | 0.030 |
Why?
| Pain Measurement | 1 | 2011 | 191 | 0.030 |
Why?
| Recovery of Function | 1 | 2011 | 148 | 0.030 |
Why?
| Receptors, Antigen, T-Cell | 1 | 1991 | 227 | 0.030 |
Why?
| Epidemiologic Methods | 1 | 2009 | 66 | 0.030 |
Why?
| Absorptiometry, Photon | 1 | 2009 | 61 | 0.030 |
Why?
| Osteitis | 1 | 2009 | 1 | 0.030 |
Why?
| Deoxyribonuclease I | 1 | 1989 | 39 | 0.030 |
Why?
| Rheumatoid Nodule | 1 | 1989 | 2 | 0.030 |
Why?
| Lumbar Vertebrae | 1 | 2009 | 65 | 0.030 |
Why?
| Patient Satisfaction | 1 | 2011 | 265 | 0.030 |
Why?
| Aorta, Abdominal | 1 | 1989 | 39 | 0.030 |
Why?
| Mice, Nude | 1 | 1989 | 199 | 0.030 |
Why?
| Health Status | 1 | 2011 | 315 | 0.030 |
Why?
| Vasculitis | 1 | 1989 | 45 | 0.030 |
Why?
| Spondylitis | 1 | 1988 | 1 | 0.030 |
Why?
| Postmenopause | 1 | 2009 | 217 | 0.030 |
Why?
| Outcome Assessment (Health Care) | 1 | 2011 | 407 | 0.030 |
Why?
| Spleen | 1 | 1989 | 454 | 0.030 |
Why?
| Magnetic Resonance Imaging | 1 | 2013 | 979 | 0.020 |
Why?
| Quality of Life | 1 | 2011 | 437 | 0.020 |
Why?
| Mutation | 2 | 2005 | 1737 | 0.020 |
Why?
| Mice, Inbred BALB C | 2 | 2000 | 806 | 0.020 |
Why?
| Age Factors | 1 | 2009 | 1100 | 0.020 |
Why?
| Cell Nucleus | 1 | 1989 | 494 | 0.020 |
Why?
| Fos-Related Antigen-2 | 1 | 2005 | 1 | 0.020 |
Why?
| Matrix Metalloproteinase 13 | 1 | 2005 | 4 | 0.020 |
Why?
| Smad1 Protein | 1 | 2005 | 6 | 0.020 |
Why?
| Cross-Sectional Studies | 1 | 2009 | 1197 | 0.020 |
Why?
| Tibia | 1 | 2005 | 30 | 0.020 |
Why?
| Femur | 1 | 2005 | 30 | 0.020 |
Why?
| Bone Morphogenetic Proteins | 1 | 2005 | 45 | 0.020 |
Why?
| Bone Morphogenetic Protein 2 | 1 | 2005 | 43 | 0.020 |
Why?
| Immunoprecipitation | 1 | 2005 | 118 | 0.020 |
Why?
| Cyclooxygenase 2 | 1 | 2005 | 54 | 0.020 |
Why?
| Plasmids | 1 | 2005 | 244 | 0.020 |
Why?
| Transforming Growth Factor beta | 1 | 2005 | 140 | 0.020 |
Why?
| Core Binding Factor Alpha 1 Subunit | 1 | 2005 | 134 | 0.020 |
Why?
| Chemotaxis | 1 | 2004 | 37 | 0.020 |
Why?
| Transcription Factor AP-1 | 1 | 2004 | 40 | 0.020 |
Why?
| NIH 3T3 Cells | 1 | 2004 | 85 | 0.020 |
Why?
| Transfection | 1 | 2005 | 636 | 0.020 |
Why?
| DNA Mutational Analysis | 1 | 2004 | 148 | 0.020 |
Why?
| Cell Cycle | 1 | 2005 | 344 | 0.020 |
Why?
| Oligonucleotide Probes | 1 | 2003 | 42 | 0.020 |
Why?
| DNA Damage | 1 | 2005 | 244 | 0.020 |
Why?
| Oligonucleotides | 1 | 2004 | 94 | 0.020 |
Why?
| Mutagenesis, Site-Directed | 1 | 2004 | 247 | 0.020 |
Why?
| Transcriptional Activation | 1 | 2004 | 199 | 0.020 |
Why?
| Tarsus, Animal | 1 | 2002 | 1 | 0.020 |
Why?
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2002 | 20 | 0.020 |
Why?
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2002 | 32 | 0.020 |
Why?
| Immunization, Passive | 1 | 2002 | 85 | 0.020 |
Why?
| Back | 1 | 2001 | 5 | 0.020 |
Why?
| Forehead | 1 | 2001 | 13 | 0.020 |
Why?
| Thorax | 1 | 2001 | 23 | 0.020 |
Why?
| Endopeptidases | 1 | 2002 | 61 | 0.020 |
Why?
| Chimera | 1 | 2001 | 39 | 0.020 |
Why?
| Polyomavirus | 1 | 2001 | 26 | 0.020 |
Why?
| Binding Sites | 1 | 2004 | 749 | 0.020 |
Why?
| Interleukin-6 | 1 | 2002 | 231 | 0.020 |
Why?
| Immunophenotyping | 1 | 2001 | 167 | 0.020 |
Why?
| RNA, Small Interfering | 1 | 2005 | 574 | 0.020 |
Why?
| Antigens | 1 | 2001 | 160 | 0.010 |
Why?
| Genetic Vectors | 1 | 2004 | 484 | 0.010 |
Why?
| Apoptosis | 1 | 2005 | 868 | 0.010 |
Why?
| Protein Binding | 1 | 2004 | 1223 | 0.010 |
Why?
| Genetic Predisposition to Disease | 1 | 2002 | 456 | 0.010 |
Why?
| Genes, Tumor Suppressor | 1 | 2000 | 76 | 0.010 |
Why?
| Cell Division | 1 | 2000 | 431 | 0.010 |
Why?
| Tooth Extraction | 1 | 1968 | 6 | 0.010 |
Why?
| Calcineurin | 1 | 1998 | 20 | 0.010 |
Why?
| Stem Cells | 1 | 2000 | 202 | 0.010 |
Why?
| Gene Targeting | 1 | 1998 | 74 | 0.010 |
Why?
| Immunoglobulin E | 1 | 1998 | 95 | 0.010 |
Why?
| Morphogenesis | 1 | 1998 | 103 | 0.010 |
Why?
| Surgical Wound Infection | 1 | 1968 | 60 | 0.010 |
Why?
| Single-Blind Method | 1 | 1997 | 71 | 0.010 |
Why?
| Alleles | 1 | 1998 | 308 | 0.010 |
Why?
| Endothelium, Vascular | 1 | 1998 | 186 | 0.010 |
Why?
| Recombinant Fusion Proteins | 1 | 1998 | 477 | 0.010 |
Why?
| Anti-Bacterial Agents | 1 | 1968 | 382 | 0.010 |
Why?
| Ear, Inner | 1 | 1973 | 4 | 0.010 |
Why?
| Vibrissae | 1 | 1993 | 4 | 0.010 |
Why?
| Tooth | 1 | 1993 | 5 | 0.010 |
Why?
| Tissue Inhibitor of Metalloproteinases | 1 | 1993 | 6 | 0.010 |
Why?
| Alkaline Phosphatase | 1 | 1993 | 29 | 0.010 |
Why?
| Salivary Glands | 1 | 1993 | 35 | 0.010 |
Why?
| Pancreas | 1 | 1993 | 111 | 0.010 |
Why?
| Tuberculosis | 1 | 1973 | 121 | 0.010 |
Why?
| Adipose Tissue | 1 | 1993 | 226 | 0.010 |
Why?
| Retrospective Studies | 1 | 1997 | 2553 | 0.010 |
Why?
| Pregnancy | 1 | 1993 | 1207 | 0.010 |
Why?
| Polymyxins | 1 | 1968 | 1 | 0.000 |
Why?
| Tyrothricin | 1 | 1968 | 1 | 0.000 |
Why?
| Tetracaine | 1 | 1968 | 6 | 0.000 |
Why?
| Neomycin | 1 | 1968 | 8 | 0.000 |
Why?
| Rats | 1 | 1968 | 1762 | 0.000 |
Why?
|
|
Gravallese's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|